Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Erasmus School of Economics & Department of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Health Econ. 2018 Nov;27(11):1699-1716. doi: 10.1002/hec.3795. Epub 2018 Jul 3.
In most medical decisions, probabilities are ambiguous and not objectively known. Empirical evidence suggests that people's preferences are affected by ambiguity. Health economic analyses generally ignore ambiguity preferences and assume that they are the same as preferences under risk. We show how health preferences can be measured under ambiguity, and we compare them with health preferences under risk. We assume a general ambiguity model that includes many of the ambiguity models that have been proposed in the literature. For health gains, ambiguity preferences and risk preferences were indeed the same. For health losses, they differed with subjects being more pessimistic in decision under ambiguity. Utility and loss aversion were the same for risk and ambiguity. Our results imply that reducing the clinical ambiguity of health losses has more impact than reducing the ambiguity of health gains, that utilities elicited with known probabilities may not carry over to an ambiguous setting, and that ambiguity aversion may impact value of information analyses if losses are involved. These findings are highly relevant for medical decision making, because most medical interventions involve losses.
在大多数医疗决策中,概率是模糊的,并且无法客观获知。实证证据表明,人们的偏好会受到模糊性的影响。健康经济学分析通常忽略模糊偏好,并假设它们与风险下的偏好相同。我们展示了如何在模糊性下测量健康偏好,并将其与风险下的健康偏好进行比较。我们假设了一个通用的模糊模型,其中包括了文献中提出的许多模糊模型。对于健康收益,模糊偏好和风险偏好确实是相同的。对于健康损失,由于在模糊性下进行决策的主体更加悲观,因此它们有所不同。风险和模糊性下的效用和损失厌恶是相同的。我们的结果表明,减少健康损失的临床模糊性比减少健康收益的模糊性更有影响,使用已知概率得出的效用可能不适用于模糊环境,并且如果涉及损失,厌恶模糊性可能会影响信息分析的价值。这些发现对于医疗决策具有高度相关性,因为大多数医疗干预都涉及损失。